First trial over heartburn drug Zantac cancer claims expected in November Ruchika Sharma3 July 2023 2:30 PM ISTNew York: The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state...
GSK concludes acquisition of BELLUS Health Ruchika Sharma29 Jun 2023 1:30 PM ISTUpon completion of the Arrangement, GSK acquired all outstanding common shares of BELLUS for US$14.75 per common share in cash, representing a total...
USFDA grants fast track designation for GSK Neisseria gonorrhoeae investigational vaccine Ruchika Sharma27 Jun 2023 1:30 PM ISTGonorrhoea is a sexually transmitted infection caused by a bacterium called Neisseria gonorrhoeae.
Japan approves GSK shingles vaccine Shingrix for at risk adults aged 18 and over Ruchika Sharma27 Jun 2023 12:30 PM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved an updated indication for Shingrix...
GSK reaches settlement in US Zantac litigation Ruchika Sharma23 Jun 2023 1:30 PM ISTUnited States: GSK Plc on Friday said it reached a confidential settlement of a litigation in the United States over claims that the British...
CDC panel advises Respiratory syncytial virus vaccination for elders Jacinthlyn Sylvia23 Jun 2023 9:30 AM ISTThe newly authorized respiratory syncytial virus (RSV) vaccinations should be given to persons aged 60 to 64 and 65 and older, according to the...
USFDA extends review period of GSK Momelotinib by three months Ruchika Sharma17 Jun 2023 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for...
GSK gets European Commission nod for RSV vaccine Arexvy for older adults Ruchika Sharma7 Jun 2023 1:30 PM ISTRespiratory syncytial virus vaccine, adjuvanted, contains recombinant glycoprotein F stabilised in the prefusion conformation.
GSK supplemental application for Jemperli plus chemotherapy accepted by USFDA for endometrial cancer Ruchika Sharma6 Jun 2023 3:28 PM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
GSK Pharma reports net profit at Rs 133 crore in Q4 Ruchika Sharma18 May 2023 2:30 PM ISTFor FY23, consolidated net profit from continuing operations was Rs 607.64 crore against Rs 380.77 crore in FY22.
US Supreme Court rejects Teva challenge to USD 235 million GSK award in patent dispute Ruchika Sharma16 May 2023 2:44 PM ISTGSK responded in a court brief that the case "presents no threat to generic companies who operate properly under the law."
Canada court dismissed Zantac litigation: GSK Ruchika Sharma13 May 2023 12:30 PM ISTBengaluru: The British Columbia Supreme Court dismissed a proposed class action in Canada against heartburn drug Zantac over increased cancer risk,...
